Patents matching “calcium”

US 7378496

hKCa3/KCNN3 small conductance calcium activated potassium channel: a diagnostic marker and therapeutic target

The Regents of the University of California · Granted May 27, 2008 · Expires May 22, 2028

US 7374776

Bone-filling composition for stimulating bone-forming and bone-consolidation comprising calcium sulfate and viscous biopolymers

REGENBiotech, Inc. · Granted May 20, 2008 · Expires May 15, 2028

US 7342120

Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 11, 2008 · Expires Mar 6, 2028

US 7256212

Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Aug 14, 2007 · Expires Aug 9, 2027

US 7189861

Processes for preparing amorphous atorvastatin hemi-calcium

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 13, 2007 · Expires Mar 8, 2027

US 7161012

Processes for preparing amorphous atorvastatin hemi-calcium

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jan 9, 2007 · Expires Jan 4, 2027

US 7151183

Processes for preparing amorphous atorvastatin hemi-calcium

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Dec 19, 2006 · Expires Dec 14, 2026

US 7144916

Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Dec 5, 2006 · Expires Nov 30, 2026

US 7122681

Desolvation process for the production of atorvastatin hemi-calcium essentially free of bound organic solvent

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Oct 17, 2006 · Expires Oct 12, 2026

US 7101909

Calcium channel drugs and uses

Theravance, Inc. · Granted Sep 5, 2006 · Expires Aug 31, 2026

US 6992194

Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jan 31, 2006 · Expires Jan 26, 2026

US 6979724

Calcium channel proteins

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Dec 27, 2005 · Expires Dec 22, 2025

US 6897305

Calcium channel drugs and uses

Theravance, Inc. · Granted May 24, 2005 · Expires May 19, 2025

US 6653100

hKCa3/KCNN3 small conductance calcium activated potassium channel: A diagnostic marker and therapeutic target

The Regents of the University of California · Granted Nov 25, 2003 · Expires Nov 20, 2023

US 6605636

Atorvastatin hemi-calcium form VII

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Aug 12, 2003 · Expires Aug 7, 2023

US 6528661

Hydrolysis of [R(R*,R*)]-2-(4-fluorophenyl)-&bgr;,&dgr;-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino) carbonyl]-1H-pyrrole-1-heptanoic acid esters with calcium hydroxide

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 4, 2003 · Expires Feb 27, 2023

US 6444446

Calcium binding proteolipid compositions and methods

The Board of Regents of the University of Texas System · Granted Sep 3, 2002 · Expires Aug 29, 2022

US 6441156

Calcium channel compositions and methods of use thereof

The United States of America, as represented by the Department of Health and Human Services · Granted Aug 27, 2002 · Expires Aug 22, 2022

US 6287607

Potassium calcium citrate compositions and methods therefor

The Board of Regents of the University of Texas System · Granted Sep 11, 2001 · Expires Sep 6, 2021

US 6221861

Reducing pyrophosphate deposition with calcium antagonists

The Regents of the University of California · Granted Apr 24, 2001 · Expires Apr 19, 2021

US 6165719

hKCa3/KCNN3 small conductance calcium activated potassium channel: a diagnostic marker and therapeutic target

The Regents of the University of California · Granted Dec 26, 2000 · Expires Dec 21, 2020

US 6106856

Transdermal delivery of calcium channel blockers, such as nifedipine

Board of Governors for Higher Education, State of Rhode Island and Providence Plantations · Granted Aug 22, 2000 · Expires Aug 17, 2020

US 6057346

Inhibition of retroviral LTR promoters by calcium response modifiers

The United States of America, as represented by the Department of Health and Human Services · Granted May 2, 2000 · Expires Apr 27, 2020